Polymyxin-direct hemoperfusion for sepsis-induced multiple organ failure

Area of Science:

• Hematology
• Infectious Diseases
• Critical Care Medicine

Background:

• Acute lymphoblastic leukemia (ALL) therapy can increase susceptibility to infections.
• Bacterial sepsis is a serious complication in immunocompromised patients.

Observation:

• A 15-year-old male with ALL developed Bacillus cereus sepsis and multiple organ failure during chemotherapy.
• Elevated serum inflammatory cytokines, anti-inflammatory cytokines, and plasminogen-activator inhibitor complex-1 were noted at sepsis onset.

Findings:

• Polymyxin-direct hemoperfusion and continuous hemodiafiltration were initiated for septic shock.
• The patient's condition improved following hemoperfusion therapy.
• Blood purification led to decreased levels of cytokines and bioactive substances, correlating with clinical recovery.

Implications:

• Blood purification techniques show promise in managing severe Bacillus cereus sepsis in immunocompromised patients.
• This case highlights the importance of prompt diagnosis and aggressive treatment for sepsis during leukemia therapy.
• Further research into targeted therapies for Bacillus cereus sepsis in oncology patients is warranted.